Last $54.84 USD
Change Today -0.16 / -0.29%
Volume 305.1K
Q On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

quintiles transnational hold (Q) Snapshot

Open
$55.00
Previous Close
$55.00
Day High
$55.16
Day Low
$54.56
52 Week High
07/10/14 - $55.68
52 Week Low
10/31/13 - $40.10
Market Cap
7.1B
Average Volume 10 Days
361.2K
EPS TTM
$2.23
Shares Outstanding
130.1M
EX-Date
--
P/E TM
24.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for QUINTILES TRANSNATIONAL HOLD (Q)

quintiles transnational hold (Q) Related Businessweek News

No Related Businessweek News Found

quintiles transnational hold (Q) Details

Quintiles Transnational Holdings Inc., through its subsidiary, Quintiles Transnational Corp., provides biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through two segments, Product Development and Integrated Healthcare Services. The Product Development segment provides project management and clinical monitoring services, including study design and operational planning, investigator/site recruitment, site and regulatory start up, patient recruitment, clinical monitoring, and project management for conducting various multi-site trials; and clinical trial support services comprising clinical data management, biostatistical, central laboratories, genomic laboratory, bioanalytical laboratories, cardiac safety and ECG, safety and pharmacovigilance, and phase I clinical pharmacology services. It also provides strategic planning and design services; and consulting services, such as product development strategy, regulatory and compliance, and process and IT implementation consulting services. The Integrated Healthcare Services segment offers commercial services comprising contract sales, market entry/market exit, integrated channel management, patient engagement, market access and commercialization consulting, and medical education services; communication and health engagement services, including digital patient, and brand and scientific communications services; and outcome-based services, such as observational studies, comparative effectiveness studies, and product and disease registry services. The company serves biopharmaceutical companies, including medical device and diagnostics companies. Quintiles Transnational Holdings Inc. was founded in 1982 and is based in Durham, North Carolina.

29,000 Employees
Last Reported Date: 05/1/14
Founded in 1982

quintiles transnational hold (Q) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $1.0M
Executive Chairman
Total Annual Compensation: $871.2K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $1.1M
Chief Customer & Governance Officer and Execu...
Total Annual Compensation: $838.4K
Consultant
Total Annual Compensation: $526.3K
Compensation as of Fiscal Year 2013.

quintiles transnational hold (Q) Key Developments

Basilea Pharmaceutica AG Enters into Agreement with Quintiles for the Commercialization of Zevtera(R)/Mabelio(R) in Europe

Basilea Pharmaceutica AG reported that it has entered into an agreement with Quintiles for the commercialization of Zevtera(R)/Mabelio(R) (ceftobiprole medocaril) in Europe. Under the agreement, Quintiles will provide commercial services including a dedicated field force, medical science liaisons, and market access support in selected countries.

Quintiles and Modern Marketing Concepts Launches Innovative Marketing Analytics Platform

Quintiles and Modern Marketing Concepts announced the launch of a new marketing analytics platform that enables Quintiles to optimize sales and marketing efforts on behalf of its U.S. commercialization customers. Through this collaboration, Quintiles and MMC combine proprietary channel preference data with the innovative Next Action Marketing platform to create optimized physician communication strategies that align with their preferences and behaviors.

Quintiles and American Physical Therapy Association Announce Plans to Develop New Outcomes Registry

Quintiles and the American Physical Therapy Association (APTA) announced a new strategic collaboration to develop and implement the Physical Therapy Outcomes Registry which will be the largest and most comprehensive physical therapy electronic repository to date. APTA selected Quintiles for this initiative based on Quintiles' extensive experience in post-marketing research, multi-stakeholder strategy, and systems-oriented registry design and development. Recruitment of users for a pilot version of the registry will begin in the third quarter of 2014, with a full launch envisaged for early 2015. Both Quintiles and APTA believe the Physical Therapy Outcomes Registry will be unlike any other existing physical therapy registry by providing data across the continuum of care. The registry will align with current and future quality and compliance programs required by payers, such as the Physician Quality Reporting System. The Physical Therapy Outcomes Registry will use a hub-and-spoke model to collect data, wherein data is collected from multiple sources (the 'spokes') and deposited into a centralized repository (the 'hub'). The 'spokes' include electronic health record systems, billing and documentation systems used by health systems, APTA chapters across the country, private practices, other facility-based practices, and individual physical therapists. This model will allow the largest amount of information to be collected in the most efficient manner and provide the ability to aggregate data across diverse patient populations and clinical settings in which physical therapists practice.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
Q:US $54.84 USD -0.16

Q Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bioanalytical Systems Inc $2.31 USD +0.01
View Industry Companies
 

Industry Analysis

Q

Industry Average

Valuation Q Industry Range
Price/Earnings 26.9x
Price/Sales 1.8x
Price/Book NM Not Meaningful
Price/Cash Flow 26.7x
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QUINTILES TRANSNATIONAL HOLD, please visit www.quintiles.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.